Caspase-8 Acts in a Non-enzymatic Role as a Scaffold for Assembly of a Pro-inflammatory "FADDosome" Complex upon TRAIL Stimulation
- PMID: 28212752
- DOI: 10.1016/j.molcel.2017.01.022
Caspase-8 Acts in a Non-enzymatic Role as a Scaffold for Assembly of a Pro-inflammatory "FADDosome" Complex upon TRAIL Stimulation
Abstract
TRAIL is a potent inducer of apoptosis and has been studied almost exclusively in this context. However, TRAIL can also induce NFκB-dependent expression of multiple pro-inflammatory cytokines and chemokines. Surprisingly, whereas inhibition of caspase activity blocked TRAIL-induced apoptosis, but not cytokine production, knock down or deletion of caspase-8 suppressed both outcomes, suggesting that caspase-8 participates in TRAIL-induced inflammatory signaling in a scaffold role. Consistent with this, introduction of a catalytically inactive caspase-8 mutant into CASP-8 null cells restored TRAIL-induced cytokine production, but not cell death. Furthermore, affinity precipitation of the native TRAIL receptor complex revealed that pro-caspase-8 was required for recruitment of RIPK1, via FADD, to promote NFκB activation and pro-inflammatory cytokine production downstream. Thus, caspase-8 can serve in two distinct roles in response to TRAIL receptor engagement, as a scaffold for assembly of a Caspase-8-FADD-RIPK1 "FADDosome" complex, leading to NFκB-dependent inflammation, or as a protease that promotes apoptosis.
Keywords: Caspase-8; FADDosome; Inflammation; NF-κB; RIPK1; TRAIL; apoptosis; cell death; cytokines; death receptors.
Copyright © 2017 Elsevier Inc. All rights reserved.
Similar articles
-
cFLIPL acts as a suppressor of TRAIL- and Fas-initiated inflammation by inhibiting assembly of caspase-8/FADD/RIPK1 NF-κB-activating complexes.Cell Rep. 2023 Dec 26;42(12):113476. doi: 10.1016/j.celrep.2023.113476. Epub 2023 Nov 20. Cell Rep. 2023. PMID: 37988267
-
TRAIL Receptors Serve as Stress-Associated Molecular Patterns to Promote ER-Stress-Induced Inflammation.Dev Cell. 2020 Mar 23;52(6):714-730.e5. doi: 10.1016/j.devcel.2020.01.031. Epub 2020 Feb 27. Dev Cell. 2020. PMID: 32109381
-
The adaptor protein FADD and the initiator caspase-8 mediate activation of NF-κB by TRAIL.Cell Death Dis. 2012 Oct 25;3(10):e414. doi: 10.1038/cddis.2012.154. Cell Death Dis. 2012. PMID: 23096115 Free PMC article.
-
c-FLIP, a master anti-apoptotic regulator.Exp Oncol. 2012 Oct;34(3):176-84. Exp Oncol. 2012. PMID: 23070002 Free PMC article. Review.
-
Regulation of Cancer Metastasis by TRAIL/Death Receptor Signaling.Biomolecules. 2021 Mar 26;11(4):499. doi: 10.3390/biom11040499. Biomolecules. 2021. PMID: 33810241 Free PMC article. Review.
Cited by
-
Caspase-8 in inflammatory diseases: a potential therapeutic target.Cell Mol Biol Lett. 2024 Oct 8;29(1):130. doi: 10.1186/s11658-024-00646-x. Cell Mol Biol Lett. 2024. PMID: 39379817 Free PMC article. Review.
-
Evaluation of Caspase Activation to Assess Innate Immune Cell Death.J Vis Exp. 2023 Jan 20;(191):10.3791/64308. doi: 10.3791/64308. J Vis Exp. 2023. PMID: 36744800 Free PMC article.
-
TRAIL receptors promote constitutive and inducible IL-8 secretion in non-small cell lung carcinoma.Cell Death Dis. 2022 Dec 15;13(12):1046. doi: 10.1038/s41419-022-05495-0. Cell Death Dis. 2022. PMID: 36522309 Free PMC article.
-
Delineating the role of c-FLIP/NEMO interaction in the CD95 network via rational design of molecular probes.BMC Genomics. 2019 May 8;20(Suppl 3):293. doi: 10.1186/s12864-019-5539-y. BMC Genomics. 2019. PMID: 31815628 Free PMC article.
-
Caspase-8 and Tyrosine Kinases: A Dangerous Liaison in Cancer.Cancers (Basel). 2023 Jun 21;15(13):3271. doi: 10.3390/cancers15133271. Cancers (Basel). 2023. PMID: 37444381 Free PMC article. Review.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
